Inhibrx Biosciences, Inc. (INBX)
101.32
-9.25
(-8.37%)
USD |
NASDAQ |
May 22, 16:00
101.37
+0.05
(+0.05%)
After-Hours: 20:00
Inhibrx Biosciences EPS Diluted (Quarterly) : -2.146 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Biogen, Inc. | 2.153 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Capricor Therapeutics, Inc. | -0.591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.44M |
| Total Expenses (Quarterly) | 33.44M |
| Enterprise Value | 1.506B |
| Earnings Yield | -8.28% |
| Normalized Earnings Yield | -8.280 |